A series of [1,3]thiazolo[4,5-e]isoindoles has been synthesized through a versatile and high yielding multistep sequence. Evaluation of the antiproliferative activity of the new compounds on the full NCI human tumor cell line panel highlighted several compounds that are able to inhibit tumor cell proliferation at micromolar-submicromolar concentrations. The most active derivative 11g was found to cause cell cycle arrest at the G2/M phase and induce apoptosis in HeLa cells, following the mitochondrial pathway, making it a lead compound for the discovery of new antimitotic drugs.
Spano' V., Barreca M., Rocca R., Bortolozzi R., Bai R., Carbone A., et al. (2021). Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 212, 1-17 [10.1016/j.ejmech.2020.113122].
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors
Spano' V.;Barreca M.;Carbone A.;Raimondi M. V.;Palumbo Piccionello A.;Montalbano A.
;Barraja P.
2021-02-15
Abstract
A series of [1,3]thiazolo[4,5-e]isoindoles has been synthesized through a versatile and high yielding multistep sequence. Evaluation of the antiproliferative activity of the new compounds on the full NCI human tumor cell line panel highlighted several compounds that are able to inhibit tumor cell proliferation at micromolar-submicromolar concentrations. The most active derivative 11g was found to cause cell cycle arrest at the G2/M phase and induce apoptosis in HeLa cells, following the mitochondrial pathway, making it a lead compound for the discovery of new antimitotic drugs.File | Dimensione | Formato | |
---|---|---|---|
E.J.Med.Chem. 212,2021,113122.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
1.96 MB
Formato
Adobe PDF
|
1.96 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
EJMECH-D-20-03146_Revised_Manuscript-Unmarked.pdf
accesso aperto
Tipologia:
Pre-print
Dimensione
845.73 kB
Formato
Adobe PDF
|
845.73 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.